Supply Chain | November 12, 2021
Jubilant Biosys expands Chemistry Innovation Research Centre
The centre has an initial capacity of 500 FTEs
The centre has an initial capacity of 500 FTEs
The submission is based on Phase 2/3 study of mRNA-1273 in children ages 6 to 11
The company has operations in North America, Asia, and Europe,
Its unique technology, ChetoSensar gives new promise to ADCs by alleviating solubility challenges
Through the mission an entire ecosystem for services from treatment to critical research will be created in every corner of the country
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
Key takeaways of recent quarter & conference call highlights
Key takeaways of recent quarter & conference call highlights
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
The quarter also saw continued investment in new technologies and the successful implementation of several digitization and automation projects across operations
Subscribe To Our Newsletter & Stay Updated
